120 related articles for article (PubMed ID: 2466316)
1. Subfoveal neovascularization in the ocular histoplasmosis syndrome. A natural history study.
Kleiner RC; Ratner CM; Enger C; Fine SL
Retina; 1988; 8(4):225-9. PubMed ID: 2466316
[TBL] [Abstract][Full Text] [Related]
2. Five-year follow-up of fellow eyes of individuals with ocular histoplasmosis and unilateral extrafoveal or juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1996 Jun; 114(6):677-88. PubMed ID: 8639078
[TBL] [Abstract][Full Text] [Related]
3. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis.
Berger AS; Conway M; Del Priore LV; Walker RS; Pollack JS; Kaplan HJ
Arch Ophthalmol; 1997 Aug; 115(8):991-6. PubMed ID: 9258220
[TBL] [Abstract][Full Text] [Related]
4. The influence of treatment extent on the visual acuity of eyes treated with Krypton laser for juxtafoveal choroidal neovascularization. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Feb; 113(2):190-4. PubMed ID: 7532395
[TBL] [Abstract][Full Text] [Related]
5. The natural history of idiopathic subfoveal choroidal neovascularization.
Ho AC; Yannuzzi LA; Pisicano K; DeRosa J
Ophthalmology; 1995 May; 102(5):782-9. PubMed ID: 7539905
[TBL] [Abstract][Full Text] [Related]
6. Visual results after surgical removal of subfoveal choroidal neovascular membranes.
Thomas MA; Dickinson JD; Melberg NS; Ibanez HE; Dhaliwal RS
Ophthalmology; 1994 Aug; 101(8):1384-96. PubMed ID: 7520148
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of a long-standing subfoveal neovascular membrane secondary to ocular histoplasmosis.
Wind BE; Sobol WM
Ophthalmic Surg; 1993 Jan; 24(1):36-9. PubMed ID: 7680442
[TBL] [Abstract][Full Text] [Related]
8. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: I. Ophthalmic findings from a randomized clinical trial: Submacular Surgery Trials (SST) Group H Trial: SST Report No. 9.
Hawkins BS; Bressler NM; Bressler SB; Davidorf FH; Hoskins JC; Marsh MJ; Miskala PH; Redford M; Sternberg P; Thomas MA; Toth CA;
Arch Ophthalmol; 2004 Nov; 122(11):1597-611. PubMed ID: 15534121
[TBL] [Abstract][Full Text] [Related]
9. Follow-up study in eyes with choroidal neovascularization caused by presumed ocular histoplasmosis.
Klein ML; Fine SL; Knox DL; Patz A
Am J Ophthalmol; 1977 Jun; 83(6):830-5. PubMed ID: 868984
[TBL] [Abstract][Full Text] [Related]
10. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1995 Jan; 113(1):56-61. PubMed ID: 7529993
[TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent juxtafoveal subretinal neovascular membranes with krypton red laser photocoagulation.
Olk RJ; Burgess DB
Ophthalmology; 1985 Aug; 92(8):1035-46. PubMed ID: 2413415
[TBL] [Abstract][Full Text] [Related]
12. Perfusion of the subfoveal choriocapillaris affects visual recovery after submacular surgery in presumed ocular histoplasmosis syndrome.
Akduman L; Del Priore LV; Desai VN; Olk RJ; Kaplan HJ
Am J Ophthalmol; 1997 Jan; 123(1):90-6. PubMed ID: 9186102
[TBL] [Abstract][Full Text] [Related]
13. Initial experience of inferior limited macular translocation for subfoveal choroidal neovascularization resulting from causes other than age-related macular degeneration.
Fujii GY; Humayun MS; Pieramici DJ; Schachat AP; Au Eong KG; de Juan E
Am J Ophthalmol; 2001 Jan; 131(1):90-100. PubMed ID: 11162983
[TBL] [Abstract][Full Text] [Related]
14. Surgical removal of extensive peripapillary choroidal neovascularization associated with presumed ocular histoplasmosis syndrome.
Atebara NH; Thomas MA; Holekamp NM; Mandell BA; Del Priore LV
Ophthalmology; 1998 Sep; 105(9):1598-605. PubMed ID: 9754163
[TBL] [Abstract][Full Text] [Related]
15. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results.
Holekamp NM; Thomas MA; Dickinson JD; Valluri S
Ophthalmology; 1997 Jan; 104(1):22-6. PubMed ID: 9022099
[TBL] [Abstract][Full Text] [Related]
16. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome. Visual prognosis.
Olk RJ; Burgess DB; McCormick PA
Ophthalmology; 1984 Dec; 91(12):1592-602. PubMed ID: 6084225
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series.
Saperstein DA; Rosenfeld PJ; Bressler NM; Rosa RH; Sickenberg M; Sternberg P; Aaberg TM; Aaberg TM; Reaves TA;
Ophthalmology; 2002 Aug; 109(8):1499-505. PubMed ID: 12153802
[TBL] [Abstract][Full Text] [Related]
18. Managing recurrent neovascularization after subfoveal surgery in presumed ocular histoplasmosis syndrome.
Melberg NS; Thomas MA; Dickinson JD; Valluri S
Ophthalmology; 1996 Jul; 103(7):1064-7;discussion 1067-8. PubMed ID: 8684795
[TBL] [Abstract][Full Text] [Related]
19. Krypton laser photocoagulation for neovascular lesions of ocular histoplasmosis. Results of a randomized clinical trial. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1987 Nov; 105(11):1499-507. PubMed ID: 2445326
[TBL] [Abstract][Full Text] [Related]
20. Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration. The influence of initial lesion size and initial visual acuity. Macular Photocoagulation Study Group.
Arch Ophthalmol; 1994 Apr; 112(4):480-8. PubMed ID: 7512334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
